| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |